Zevra Therapeutics (ZVRA) Tax Provisions (2014 - 2026)
Zevra Therapeutics (ZVRA) posted Tax Provisions of $6.9 million for Q1 2026, up 1280.04% on a QoQ basis from $501000.0 in Q4 2025, and up 484.94% year-over-year from $1.2 million in Q1 2025.
Zevra Therapeutics (ZVRA) Tax Provisions (2014 - 2026) Analysis & Trends
Zevra Therapeutics' Tax Provisions history runs 13 years deep, the most recent figure standing at $6.9 million for Q1 2026.
- Quarterly Tax Provisions rose 484.94% year-over-year to $6.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.2 million (down 44.77% YoY) and the FY2025 annual result came in at $3.4 million, down 77.56% from the prior year.
- Tax Provisions was $6.9 million for Q1 2026 at Zevra Therapeutics, up from $501000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $15.4 million in Q4 2024 and bottomed at -$433000.0 in Q3 2025.
- A 5-year average of $1.8 million and a median of $54000.0 in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2023 — Tax Provisions plunged 2475.0% — and 2025, when it soared 3041.43%.
- Zevra Therapeutics' Tax Provisions stood at -$34000.0 in 2022, then jumped by 620.59% to $177000.0 in 2023, then jumped by 8584.18% to $15.4 million in 2024, then slumped by 96.74% to $501000.0 in 2025, then jumped by 1280.04% to $6.9 million in 2026.
- Business Quant data shows ZVRA's Tax Provisions at $6.9 million in Q1 2026, $501000.0 in Q4 2025, and -$433000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn | 6.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.91 Mn |
| Dec 31, 2025 | 501,000.00 |
| Sep 30, 2025 | -433,000.00 |
| Jun 30, 2025 | 2.20 Mn |
| Mar 31, 2025 | 1.18 Mn |
| Dec 31, 2024 | 15.37 Mn |
| Jun 30, 2024 | 70,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Sep 30, 2023 | 177,000.00 |
| Jun 30, 2023 | -74,000.00 |
| Mar 31, 2023 | -103,000.00 |
| Dec 31, 2022 | -34,000.00 |
| Jun 30, 2022 | 38,000.00 |
| Mar 31, 2022 | -4,000.00 |
| Dec 31, 2021 | 34,000.00 |
| Sep 30, 2020 | -34,000.00 |
| Dec 31, 2019 | -8,000.00 |
| Sep 30, 2019 | 3,000.00 |
| Jun 30, 2019 | -9,000.00 |
| Mar 31, 2019 | -8,000.00 |